{
  "id": 28423,
  "title": "Merck after Keytruda: what the pipeline looks like",
  "url": "https://urgent.news/2026/07/31/merck-after-keytruda-what-the-pipeline-looks-like",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-31T13:00:00.000Z",
  "source": {
    "name": "Labiotech",
    "slug": "labiotech",
    "url": "https://www.labiotech.eu/top-pharma-strategy/merck-pipeline/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry. The post Merck after Keytruda: what the pipeline looks like appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited.…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}